Events

September 30, 2020

PING is renowned for its personalized approach, giving attendees the opportunity to develop and cement relations with existing contacts and meet new people.

September 30, 2020

As the election nears and with the recent flurry of regulatory activity surrounding drug pricing transparency, bio/pharma manufacturers must continuously stay ahead of the ever-evolving changes. Join Informa Connect-CBI’s 6th Edition Drug Pricing Transparency Congress to discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Assess how companies are planning internally for these changes, hear updates post-election impacting drug pricing transparency and gain a preview of what’s to come in 2021.

September 30, 2020

A Dialogue-Driven Meeting for Industry Trends and Next-Generation Approaches to Patient Services

September 30, 2020

The Original Forum for Life Sciences Providing Exclusive Access to FDA/CMS Regulators to Examine Shifting Regulatory and Reimbursement Policy.

September 30, 2020

Year after year, the life sciences industry marks Informa Connect-CBI’s Trade and Channel Strategies as the “go-to” event for trade, channel, market access, account strategy and brand professionals. Join hundreds of your industry counterparts this December to unravel the complexities of the channel, navigate high-impact topics transforming trade and benchmark winning pharmacy and distribution frameworks.

September 30, 2020

Consistently highly acclaimed for top quality learning and networking. Led by the industry’s most authoritative government pricing experts, a must-attend meeting with timely analyses on evolving regulatory issues, industry benchmarking by hundreds of companies on prevailing MDRP trends and strategies for government reporting.

September 30, 2020

Convening Europe’s only meeting designed specifically for meeting managers working in the Life Sciences and serving as the ideal platform to strengthen HCP compliance, grow partnerships and elevate attendee engagement.

September 30, 2020

The largest and longest standing forum focused on the role of coupon and copay programs in assisting in patient access and affordability to higher-priced drugs.

September 30, 2020

The foremost and longest-standing event for model-sharing on strategic forecasting, estimates, analytics and reporting for life science companies. With over 300 attendees, the networking is unparalleled and valuable.

September 30, 2020

Pharma, biotech, and medical device professionals will convene to stay up to date on complex state & local transparency regulations, global compliance requirements and effective HCP engagements. From the changing regulatory landscape to the latest enforcement trends, this must-attend event provides your very best opportunity to benchmark with industry peers.

September 30, 2020

The only event of its kind for compounding professionals, providing the necessary information to comply with changing quality standards.

September 30, 2020

CBI/EBD Group’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs.

September 30, 2020

A 360 degree view of the medical affairs landscape that brings together Investigator Initiated Sponsored Research (IISR), Expanded Access Programs (EAP) and Medical Publications & Communications.

September 30, 2020

This gold standard event arms the industry with strategic approaches to improve contract operations, navigate class of trade complexities, streamline membership management and reduce revenue leakage to improve chargeback efficiency and the bottom line.

September 30, 2020

Convening top Canadian compliance practitioners and leading experts to exchange ideas and discuss the impact of the latest laws, regulations and best practices for advancing compliance programs.

August 11, 2020

Pharma & Patient USA (December 1-4, 2020, Virtual – formerly eyeforpharma Patient Summit) is where industry experts, patient leaders and key stakeholders unite to devise an advanced roadmap for patient centricity that goes above and beyond, prioritizing patient needs in the post-pandemic age.